EvoGenix To List On ASX In August; Will Open Its IPO Within A Week

Antibody therapeutics company EvoGenix will open its initial public offering within a week and list on the ASX in early to mid-August, with the aim of raising AUD$9 million.

MORE ON THIS TOPIC